Clinical trial
Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
Opening soon · Not applicable · 0 countries · Registry ID NCT07168551
What this study is about
1. Identifying the association between hyperuricemia and NAFLD can lead to early detection and prevention of liver fibrosis in adult obese patients. 2. Understanding the relationship between hyperuricemia and NAFLD can inform targeted therapy, such as urate-lowering treatment, to potentially slow disease progression. 3 - To examine the relationship between serum uric acid levels and liver fibrosis severity\*: Assessing the correlation between serum uric acid levels and the severity of liver fibrosis in adult obese patients with NAFLD. 4- To identify potential mechanisms underlying the association\*: Exploring the potential mechanisms by which hyperuricemia may contribute to the development and progression of NAFLD and liver fibrosis in adult obese patients.
Basic eligibility
Full registry criteria
Treatments and study arms
*Lab Methods:* 1- Serum Uric Acid levels 2-Liver Function Tests 3- Lipid Profile . 4- Haemoglobin A1c level . 5- Serum glucose level .
Lab methods
*Imaging Studies:* 1- Ultrasound 2 - FibroScan
Imaging
Instruments:* 1- *Automated Analyzers*: Used for blood tests, such as serum uric acid and liver function tests.
Instrument
Primary outcomes
The proportion of adult obese patients with NAFLD in the study population
Study locations
0 locations were listed when this page was built. The first 40 are shown.